期刊
CIRCULATION RESEARCH
卷 132, 期 10, 页码 1387-1404出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.122.321882
关键词
COVID-19; echocardiography; magnetic resonance imaging; myocardial infarction; tomography
Infection with SARS-CoV-2, the virus that causes COVID, can lead to various cardiovascular complications. Cardiac imaging has become crucial in differentiating pulmonary and cardiovascular complications due to the non-specific symptoms and laboratory findings of COVID patients. This review summarizes the existing literature and major societal guidelines to provide an overview of the indications and utility of different cardiac imaging modalities for diagnosing cardiovascular complications of COVID.
Infection with SARS-CoV-2, the virus that causes COVID, is associated with numerous potential secondary complications. Global efforts have been dedicated to understanding the myriad potential cardiovascular sequelae which may occur during acute infection, convalescence, or recovery. Because patients often present with nonspecific symptoms and laboratory findings, cardiac imaging has emerged as an important tool for the discrimination of pulmonary and cardiovascular complications of this disease. The clinician investigating a potential COVID-related complication must account not only for the relative utility of various cardiac imaging modalities but also for the risk of infectious exposure to staff and other patients. Extraordinary clinical and scholarly efforts have brought the international medical community closer to a consensus on the appropriate indications for diagnostic cardiac imaging during this protracted pandemic. In this review, we summarize the existing literature and reference major societal guidelines to provide an overview of the indications and utility of echocardiography, nuclear imaging, cardiac computed tomography, and cardiac magnetic resonance imaging for the diagnosis of cardiovascular complications of COVID.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据